GL1X · GenesisL1 explorer

MolNFT v1 · #168998 · protein

Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 ha trimer

6WXL · Hemagglutinin HA1 chain: “Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7…”. Electron microscopy, 1 ligand (NAG), 20 pockets (best druggability 0.82). MolNFT v1 #168998 on…

PDB
6WXL
Type
protein
Length
2,175 residues
Chains
12
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin HA1 chain; Hemagglutinin HA2 chain; 1D12 light chain; 1D21 heavy chain
UniProt
A0A067Y6L0
Ligands
NAG
Pockets
20 · best druggability 0.82

Structure

electron microscopy · 4 distinct chains · 16% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, GHemagglutinin HA1 chainprotein3167% helix, 40% strandA0A067Y6L0
B, D, IHemagglutinin HA2 chainprotein17050% helix, 14% strandA0A067Y6L0
L, E, J1D12 light chainprotein1140% helix, 46% strand—
H, F, K1D21 heavy chainprotein1256% helix, 42% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 9 copies · chains A, L, B, D, I, E, C, J, G

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16610.820.8763empty
21830.810.9527empty
31770.800.9527empty
41810.800.9527empty
53550.750.8655empty

Interfaces

36 interfaces between chains.

  • I–G · 3161 Ų buried · 34 hydrogen bonds · protein-protein
  • A–B · 3149 Ų buried · 34 hydrogen bonds · protein-protein
  • D–C · 3144 Ų buried · 34 hydrogen bonds · protein-protein
  • B–D · 1278 Ų buried · 8 hydrogen bonds · protein-protein
  • D–I · 1274 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 24 disulfide, 9 glycan (disulfide, N-glycosylation).

Compared structures

  • 6WXL · Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.